US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.37

-0.0500-0.15%

Post-market: 34.370.00000.00%19:30 EDT

Volume:134.91K

Turnover:4.64M

Market Cap:105.52M

PE:- -

High:34.78

Open:34.78

Low:34.20

Close:34.42

52wk High:36.84

52wk Low:25.00

Shares:3.07M

Float Shares:3.07M

Volume Ratio:2.41

T/O Rate:4.39%

Dividend:0.39

Dividend Rate:1.14%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Hong Kong Stock Market Commentary: Housing Interest Subsidy Boosts Property Stocks, Innovative Drugs See Dense Catalysts

Hong Kong Stock Connect Innovative Drug Sector Defies Market Downturn as Top Pharmaceutical Firm Enters with US$2 Billion, Akeso Surges 15.54%, Hengrui Pharma Secures US$2.6 Billion BD Deal

Multiple Positive Catalysts Converge: Are Innovative Drugs Still the Focus for the Fourth Quarter?

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)

Court Dismisses Regeneron Pharmaceuticals (REGN) Securities Lawsuit Over Eylea and Eylea HD Claims

CSPC Pharma's JMT206 Injection Ib Phase Trial for Weight Management in Overweight or Obese Adults Officially Launches at First Site in China

CSPC Pharma's Recombinant Shingles Vaccine SYS 6052 Gains US Clinical Trial Approval

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Envista Holdings (NVST) and Regeneron (REGN)

Hong Kong Stocks Slip as Property and Biotech ETF Sectors Rally on Policy Signals

SoftOx Names Dr. Bruce Montgomery to Chair Clinical Advisory Board

China Innovation Drug ETF (03525) Rises Over 2%, Focusing on R&D-Driven Quality Innovative Drug Companies in Hong Kong and Developed Markets

Keymed Bio-B Jumps Over 9% in Afternoon Trading, Company Holds Strong Competitive Edge Across Multiple Innovative Drug Areas Including Autoimmune and Oncology

CARSGEN-B (02171) Completes First Patient Infusion in China Phase I Registration Trial of CT1190B

Teva Wins US FDA Approval for Xgeva Biosimilar Degevma

Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)

Mirum's Liver Infection Drug Lowers Virus Levels in Late-Stage Study

Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%

Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook

US Drugmakers Turn to China for Licensing Deals

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/IBBQ/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.37,"timestamp":1790971200000,"preClose":34.42,"halted":0,"volume":134914,"hourTrading":{"tag":"盘后","latestPrice":34.37,"preClose":34.37,"latestTime":"19:30 EDT","volume":23,"amount":793.71,"timestamp":1790983804820,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0014526438117374858,"floatShares":3070000,"shares":3070000,"eps":0,"marketStatus":"Market Closed","change":-0.05,"latestTime":"10-02 16:00:00 EDT","open":34.78,"high":34.78,"low":34.2,"amount":4640242.504378,"amplitude":0.016851,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":34.42,"sharesOutstanding":2520001,"nav":34.4248,"aum":106440372.14,"dividendRate":0.01135,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":34.5,"preClose":34.42,"latestTime":"07:58 EDT","volume":100,"amount":3450,"timestamp":1790942314618,"change":0.08,"changeRate":0.002324,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":34.37,"preClose":34.37,"latestTime":"19:30 EDT","volume":23,"amount":793.71,"timestamp":1790983804820,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.412124809157592,"impliedVol":0.1226,"impliedVolPercentile":0.5299},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":3070000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.412124809157592,"shares":3070000,"dividePrice":0.3901,"high":34.78,"amplitude":0.016851,"preClose":34.42,"low":34.2,"week52Low":25,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.37,"eps":0,"divideRate":0.01135,"volume":134914,"delay":0,"ttmEps":0,"open":34.78,"prevYearClose":28.3962,"prevWeekClose":35,"prevMonthClose":35.14,"prevQuarterClose":35.14,"fiveDayClose":35,"twentyDayClose":36.26,"sixtyDayClose":33.97},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"IBBQ","amount":0.23037,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1161134760","title":"Hong Kong Stock Market Commentary: Housing Interest Subsidy Boosts Property Stocks, Innovative Drugs See Dense Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1161134760","media":"Stock News","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161134760?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:30","pubTimestamp":1790685036,"startTime":"0","endTime":"0","summary":"Dissecting the Market: Before the holiday, various funds are engaging in all sorts of maneuvering. A-shares fell heavily over the past two days but finally rebounded today, while Hong Kong stocks...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03996","IE0008369823.USD","LU0708995583.HKD","MEDX","BK1105","BK1179","LU0082770016.SGD","06978","IE0008368742.USD","SGXZ86797644.SGD","00552","VXUS","LU0082770016.USD","BK1205","02128","LU0052750758.USD","BK4588","LU0164939612.USD","03393","LU0320764599.SGD","159992","LNGR","IBBQ","BK1555","LU0620787316.HKD","BK1148","BK1506","01081","BK4585","SG9999014674.SGD","03301","BK1240","SG9999002950.SGD","SGXZ62798434.SGD","KCAI","LU1808992512.USD","BK1529","BK1574","BK1161","SG9999001069.SGD","IE00B031HY20.USD","SG9999003461.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173705860","title":"Hong Kong Stock Connect Innovative Drug Sector Defies Market Downturn as Top Pharmaceutical Firm Enters with US$2 Billion, Akeso Surges 15.54%, Hengrui Pharma Secures US$2.6 Billion BD Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1173705860","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173705860?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:20","pubTimestamp":1790680850,"startTime":"0","endTime":"0","summary":"On September 29, the Hong Kong stock market retreated, but innovative drugs led gains against the broader trend. The Hang Seng Stock Connect Innovative Drug ETF (520880) tracking index, with 100%...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2495084118.USD","LU0359202008.SGD","KURE","LU1781817850.SGD","IE00BPRC5H50.USD","LU0405327148.USD","LU1997245094.SGD","LU2097828557.USD","LU2543165471.USD","LU2778985437.USD","LU1820825898.SGD","LU1969619763.USD","LU2097828631.EUR","LU2328871848.SGD","LU0348784397.USD","LU0348825331.USD","LU2476274308.USD","06978","BK0028","LU1064131003.USD","LU1720050803.USD","IE00B543WZ88.USD","LU0405327494.USD","LU1064130708.USD","LU1961090484.USD","LU2097828474.EUR","LU2148510915.USD","MEDX","BK0196","09926","LU1328615791.USD","600276","LU0348783233.USD","BK0012","LU2488822045.USD","BK0188","LU0348767384.USD","LU0561508036.HKD","LU2580892789.USD","LNGR","LU2476274720.SGD","LU0348827113.USD","LU0634319403.HKD","LU2580892862.HKD","LU1580142542.USD","LU0359201885.HKD","LU0348766576.USD","159992","LU1655091616.SGD","LU0417516571.SGD","LU1023057109.AUD","LU0359201612.USD","LU0348735423.USD","LU2289578879.USD","LU0417516738.SGD","BK0183","IBBQ","IE00B5MMRT66.SGD","LU1997245177.USD","FLHK","LU1794554557.SGD","LU1255011170.USD","BK0239","LU2399975544.HKD","01276","BK1161","LU2097828714.EUR","BK1574","LU1146622755.USD","LU2097828805.USD","BK1191","LU0540923850.HKD","BK0060","LU0417516902.SGD","LU1997244956.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110462263","title":"Multiple Positive Catalysts Converge: Are Innovative Drugs Still the Focus for the Fourth Quarter?","url":"https://stock-news.laohu8.com/highlight/detail?id=1110462263","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110462263?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:10","pubTimestamp":1790680230,"startTime":"0","endTime":"0","summary":"Positive developments across policy, industry, pharmaceutical companies, AIDD, and corporate performance are resonating together.Is innovative drugs still the key theme to watch in the fourth...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1161","IBBQ","BK1574","LNGR","06978","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216266","title":"Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216266","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216266?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:10","pubTimestamp":1790680206,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Summit Therapeutics (SMMT), Ocular Therapeutix (OC...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-ocular-therapeutix-ocul-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-ocular-therapeutix-ocul-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REGN","LU0114720955.EUR","LU0823434740.USD","LU2362540622.SGD","LU0823434583.USD","LU0889565916.HKD","HCSG","BK4137","LU2362541273.HKD","OCUL","SMMT","BBH","BK4139","XLV","LU0320765992.SGD","LU0053666078.USD","LU0058720904.USD","LU0882574055.USD","BK4581","XBI","LU1974910355.USD","LU2089984988.USD","LU2106854487.HKD","BK4007","LU0128526141.USD","LABU","TBXU","IBB","LU2362541513.USD","IBBQ","LU0823416689.USD","BK4588","LU1917777945.USD","BK4585","LU2023250504.SGD","LU0289739699.SGD","LU2488822045.USD","LU0109394709.USD","LU0029874061.USD","LU2237438978.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671215313","title":"Court Dismisses Regeneron Pharmaceuticals (REGN) Securities Lawsuit Over Eylea and Eylea HD Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2671215313","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671215313?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:31","pubTimestamp":1790677875,"startTime":"0","endTime":"0","summary":"A federal judge has dismissed a securities fraud lawsuit against Regeneron Pharmaceuticals ($REGN) and several of its executives, with the court di...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/court-dismisses-regeneron-pharmaceuticals-regn-securities-lawsuit-over-eylea-and-eylea-hd-claims?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/court-dismisses-regeneron-pharmaceuticals-regn-securities-lawsuit-over-eylea-and-eylea-hd-claims?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU2468319806.SGD","LU0114720955.EUR","BK4585","LU0823434583.USD","LU0823434740.USD","LU2237438978.USD","IBB","IBBQ","LU0889565916.HKD","BBH","LU1917777945.USD","LU2023250504.SGD","LU2106854487.HKD","LU0053666078.USD","TBXU","LU0058720904.USD","LU2089984988.USD","LU2362541513.USD","LU0109394709.USD","LU1974910355.USD","BK4139","LU2362540622.SGD","LU2362541273.HKD","BK4588","LU0823416689.USD","REGN","LU0882574055.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195483618","title":"CSPC Pharma's JMT206 Injection Ib Phase Trial for Weight Management in Overweight or Obese Adults Officially Launches at First Site in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1195483618","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195483618?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:09","pubTimestamp":1790676579,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group Limited (01093) has announced that the Phase Ib clinical trial (JMT206–003) of its self-developed JMT206 Injection for weight management in overweight or obese adult...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287875.USD","LU2039709279.SGD","MDTX","PSYK","IE00B543WZ88.USD","BK1515","LU1226287529.USD","IBBJ","LU0501845795.SGD","IE00B031HY20.USD","LU0315179316.USD","IE00B5MMRT66.SGD","LU1008478684.HKD","LU1993786604.SGD","HK0000165453.HKD","LU1152091754.HKD","SG9999004220.SGD","LU0072913022.USD","BK1191","IE00BZ08YT58.USD","LU0067412154.USD","LU1226288170.HKD","LU1951186391.HKD","LU0326950275.SGD","IE00BZ08YS42.EUR","LU1328277881.USD","LU0314109678.HKD","LU1807302812.USD","IE0008369823.USD","LU0880133367.SGD","LU1226288253.USD","LU1226287792.SGD","BMED","LU1813983027.USD","LU1152091168.USD","01093","LU0140636845.USD","IE0008368742.USD","BK1521","IE00BZ08YR35.GBP","LU1960683339.HKD","KURE","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154469835","title":"CSPC Pharma's Recombinant Shingles Vaccine SYS 6052 Gains US Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1154469835","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154469835?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:08","pubTimestamp":1790676512,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its Class 1 preventive biological product, the recombinant shingles vaccine (SYS 6052), has received approval from the US Food and Drug Administration (FDA) to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0501845795.SGD","IE00B031HY20.USD","LU1152091754.HKD","159646","IBBQ","LU1008478684.HKD","LU1226287529.USD","LU1807302812.USD","PSYK","KURE","SG9999004220.SGD","IE00BZ08YT58.USD","IBBJ","LU2039709279.SGD","LU1960683339.HKD","IE00B543WZ88.USD","LU0314109678.HKD","IE0008368742.USD","LU0315179316.USD","LU0067412154.USD","LU0880133367.SGD","LU1226287875.USD","LU1152091168.USD","IE00BZ08YS42.EUR","LU1328277881.USD","BMED","IE00B5MMRT66.SGD","LU0140636845.USD","HK0000165453.HKD","LU1226287792.SGD","BK1515","LU1226288253.USD","01093","LU1226288170.HKD","BK1521","LU0326950275.SGD","MDTX","IE0008369823.USD","LU1813983027.USD","IE00BZ08YR35.GBP","LU1951186391.HKD","LU0072913022.USD","LU1993786604.SGD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671290718","title":"Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Envista Holdings (NVST) and Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671290718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671290718?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:30","pubTimestamp":1790674217,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on 4D Molecular Therapeutics (FDMT), Envista Holdings...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-4d-molecular-therapeutics-fdmt-envista-holdings-nvst-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-4d-molecular-therapeutics-fdmt-envista-holdings-nvst-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0034390439.USD","LU0128526141.USD","LU2362541513.USD","LU2468319806.SGD","LU0823416689.USD","BK4082","LU0648000940.SGD","LU0029874061.USD","BK4137","LU0823434583.USD","BK4585","LU1917777945.USD","LU0823434740.USD","LU2023250504.SGD","NVST","IBB","LU0320765992.SGD","BK4581","FDMT","LU2362540622.SGD","LU0889565916.HKD","LU0882574055.USD","LU2089984988.USD","XBI","IE00B19Z6F94.USD","LU0053666078.USD","HCSG","LABU","LU0114720955.EUR","LU1974910355.USD","XLV","LU0058720904.USD","LU1201861165.SGD","BK4588","TBXU","LU0109394709.USD","BBH","LU0130518102.USD","LU0289739699.SGD","LU2106854487.HKD","LU2362541273.HKD","LU0477156797.USD","REGN","LU2237438978.USD","BK4139","LU0130103400.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113675289","title":"Hong Kong Stocks Slip as Property and Biotech ETF Sectors Rally on Policy Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=1113675289","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113675289?lang=en_us&edition=fundamental","pubTime":"2026-09-29 16:43","pubTimestamp":1790671392,"startTime":"0","endTime":"0","summary":"Hong Kong's three major indices closed slightly lower today, with heavyweight technology stocks weakening and structural divergence across the board standing out, while mainland property and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","MEDX","159992","BK4588","BK4585","IBBQ","06978","BK4550","FDN","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671329926","title":"SoftOx Names Dr. Bruce Montgomery to Chair Clinical Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2671329926","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671329926?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:23","pubTimestamp":1790666588,"startTime":"0","endTime":"0","summary":"SoftOx names Dr. Bruce Montgomery to chair Clinical Advisory BoardSoftOx appointed Dr. A. Bruce Montgomery to establish and chair its Clinical Advisory Board ahead of a planned Phase 2b SIS study.Boar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDLbDg5Mx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","GILD","LU1934455277.USD","BK4568","IE0002270589.USD","LU1066051498.USD","BBH","BIB","LU2357627491.SGD","LU0823416689.USD","SG9999015986.USD","BK4578","IE00BZ1G4Q59.USD","LU1571399168.USD","LU2089984988.USD","SG9999015978.USD","TMED","LU0965509010.AUD","MEDI","LU1934455194.USD","BK4588","IE00B7SZLL34.SGD","LU0320765992.SGD","LU1674673428.USD","BK4585","BK4583","LU1839511570.USD","LU1057294990.SGD","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD","LU0965509101.SGD","LU1934455863.HKD","LU0289739699.SGD","IBBQ","LU0234570918.USD","IE00B19Z3B42.SGD","BK4566","BK4139","BK4550","IE00BSNM7G36.USD","IE00B3T34201.USD","LU0882574055.USD","LU0965509283.SGD","LU1066053197.SGD","LU2112291526.USD","LU0859254822.USD","TBXU","LU1778281490.HKD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113085280","title":"China Innovation Drug ETF (03525) Rises Over 2%, Focusing on R&D-Driven Quality Innovative Drug Companies in Hong Kong and Developed Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1113085280","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113085280?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:22","pubTimestamp":1790666534,"startTime":"0","endTime":"0","summary":"According to Zhitong Finance APP, China Innovation Drug ETF (03525) rose over 2%, reaching 2% as of press time, at HK$10.2, with a turnover of HK$491,300.It is reported that the China Innovation Drug...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WSGE","03525","MEDX","BK4588","LNGR","BK1574","IBBQ","FDN","BK1161","BK4585","159992","06978","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110569578","title":"Keymed Bio-B Jumps Over 9% in Afternoon Trading, Company Holds Strong Competitive Edge Across Multiple Innovative Drug Areas Including Autoimmune and Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=1110569578","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110569578?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:50","pubTimestamp":1790661039,"startTime":"0","endTime":"0","summary":"Keymed Bio-B (02162) rose more than 8% in afternoon trading, climbing 8.95% as of press time to HKD 79.70, with a turnover of HKD 237 million.Earlier this month, Keymed Bio-B (02162) announced that...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1587","BK1161","02162","IBBQ","BK1583","MEDX","BK1574","159992","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146102396","title":"CARSGEN-B (02171) Completes First Patient Infusion in China Phase I Registration Trial of CT1190B","url":"https://stock-news.laohu8.com/highlight/detail?id=1146102396","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146102396?lang=en_us&edition=fundamental","pubTime":"2026-09-29 08:10","pubTimestamp":1790640613,"startTime":"0","endTime":"0","summary":"According to an announcement by CARSGEN-B (02171), CT1190B, a universal CAR-T cell product targeting CD19/CD20, has completed the first patient infusion in its Phase I registration clinical trial...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171","IBBJ","PSYK","BK1585","BK1587","BMED","MDTX","IBBQ","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671257160","title":"Teva Wins US FDA Approval for Xgeva Biosimilar Degevma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671257160","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671257160?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:00","pubTimestamp":1790625646,"startTime":"0","endTime":"0","summary":"Teva wins US FDA approval for Xgeva biosimilar DEGEVMATeva won FDA clearance for DEGEVMA (denosumab-adet), a biosimilar to Amgen’s Xgeva.Label covers Xgeva’s full uses, including prevention of bone co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL4w4Bbr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","BK4588","IE0002141913.USD","BK4566","LU2112291526.USD","NDAQ","SG9999014013.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","BCDF","LU2468319806.SGD","SG9999014039.USD","IBB","IE00BJT1NW94.SGD","IE00BQXX3D17.EUR","BK4112","LU2242646821.SGD","LU0889565916.HKD","LU1571399168.USD","LU0320765992.SGD","LU1061106388.HKD","LU2089984988.USD","TBXU","BK4585","BK4599","IBBQ","IE00B64PRP62.GBP","LU0122379950.USD","IE00B4R5TH58.HKD","SG9999014021.USD","AMGN","PBE","LU2242652126.USD","PJP","LU0289739699.SGD","IE00BN0W2V16.EUR","BBH","LU0314104364.USD","LU1057294990.SGD","IE00BKPKM429.USD","LU1983299246.USD","SG9999001440.SGD","BK4534","BK4139","BIB","IE00BN0W2W23.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","BK4533","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671252933","title":"Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone","url":"https://stock-news.laohu8.com/highlight/detail?id=2671252933","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671252933?lang=en_us&edition=fundamental","pubTime":"2026-09-29 02:37","pubTimestamp":1790620623,"startTime":"0","endTime":"0","summary":"BUZZ-Ocular Therapeutix tumbles on rival Kodiak's trial win, analyst calls selloff overdone** Shares of Ocular TherapeutixOCUL.Ofall 18.8% to $7.84 in afternoon trading** Kodiak Sciences'KOD.Oexperime","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K1CH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823434740.USD","BK4007","IBBQ","REGN","OCUL","LU0882574055.USD","BK4585","LU0058720904.USD","LU1917777945.USD","LU2362541273.HKD","LU0053666078.USD","KOD","LU0823416689.USD","BBH","BK4505","LU1974910355.USD","TBXU","BK4588","LU0889565916.HKD","LU0320765992.SGD","LU2106854487.HKD","LU2362540622.SGD","LU0109394709.USD","LU0114720955.EUR","LU2362541513.USD","LU2237438978.USD","LU0289739699.SGD","LU0823434583.USD","LU2023250504.SGD","LU2089984988.USD","LU2468319806.SGD","IBB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671259773","title":"Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671259773","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671259773?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:00","pubTimestamp":1790611227,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Regeneron (REGN) and Kodiak Sciences (KOD). Regeneron (REGN) Citi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","LU0320765992.SGD","LU2106854487.HKD","LU2362540622.SGD","KOD","LU0029874061.USD","LU0889565916.HKD","BK4585","XBI","LU0114720955.EUR","LU1974910355.USD","BK4581","LU2362541513.USD","REGN","LU2023250504.SGD","LU0058720904.USD","LU0823416689.USD","LU2362541273.HKD","BK4137","IBB","LU0053666078.USD","LU0823434740.USD","XLV","IBBQ","LABU","BK4505","BK4588","LU0128526141.USD","LU0289739699.SGD","LU0882574055.USD","LU2089984988.USD","LU0823434583.USD","LU2468319806.SGD","TBXU","HCSG","LU0109394709.USD","LU1917777945.USD","LU2237438978.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670564812","title":"Mirum's Liver Infection Drug Lowers Virus Levels in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670564812","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670564812?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:23","pubTimestamp":1790609027,"startTime":"0","endTime":"0","summary":"UPDATE 1-Mirum's liver infection drug lowers virus levels in late-stage studySept 28 (Reuters)-Mirum PharmaceuticalsMIRM.Oon Monday said its experimental hepatitis drug reduced levels of the virus in ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K14L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LU1023059063.AUD","LU1430594728.SGD","LU0058720904.USD","LU1585245621.USD","LU2468319806.SGD","IBBQ","LU2089984988.USD","TMED","GILD","MEDI","BIB","LU1057294990.SGD","LU0861579265.USD","LU0965509283.SGD","LU0234570918.USD","LU1674673428.USD","LU2324357040.USD","LU1066053197.SGD","BK4585","LU2087621335.USD","SG9999015986.USD","LU0965509101.SGD","BK4532","IE00BSNM7G36.USD","LU1778281490.HKD","LU0289739699.SGD","MIRM","BBH","LU2357627491.SGD","LU0122379950.USD","TBXU","LU0859254822.USD","IBB","IE00B19Z3581.USD","IE0002270589.USD","IE00B3T34201.USD","LU0889565916.HKD","LU2112291526.USD","BK4139","LU1839511570.USD","LU1934455863.HKD","LU1066051498.USD","IE00BKVL7J92.USD","LU0882574055.USD","BK4588","LU1934455194.USD","BK4566","SG9999015952.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670620256","title":"Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670620256","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670620256?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:11","pubTimestamp":1790608260,"startTime":"0","endTime":"0","summary":"Shares of Kodiak Sciences more than doubled Monday after two experimental eye drugs succeeded in a late-stage trial, positioning the biopharmaceutical company to get its first product to market.Kodiak","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541513.USD","LU2089984988.USD","BK4505","KOD","BK4588","BBH","LU0823416689.USD","TBXU","LU2023250504.SGD","LU0109394709.USD","LU1974910355.USD","LU2362541273.HKD","BK4585","LU0823434583.USD","LU2468319806.SGD","LU2362540622.SGD","BK4139","IBB","LU0889565916.HKD","LU0823434740.USD","IBBQ","LU0289739699.SGD","LU2237438978.USD","OTLK","LU0320765992.SGD","LU0882574055.USD","LU0058720904.USD","LU0114720955.EUR","LU2106854487.HKD","REGN","LU0053666078.USD","LU1917777945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670256598","title":"Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2670256598","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670256598?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:00","pubTimestamp":1790607600,"startTime":"0","endTime":"0","summary":"TradingKey - Amgen’s latest Sjögren’s trial success adds to its pipeline, while Repatha growth and MariTide trials shape the AMGN stock outlook for 2026.","market":"other","thumbnail":"https://resource.tradingkey.com/uploads/20260928/AMGEN-b0736da492b74294b066d7d43a826369.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260928/AMGEN-b0736da492b74294b066d7d43a826369.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262189733-stocks-amgen-stock-forecast-sjogrens-trial-maritide-2026-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU0310800379.SGD","LU2242652126.USD","TBXU","PBE","LU2468319806.SGD","IE0002141913.USD","IBB","LU0058720904.USD","LU0289739699.SGD","LU0320765992.SGD","LU2236285917.USD","BK4581","BK4588","LU2112291526.USD","LU2237443895.HKD","BK4566","AZNH","BBH","LU0029864427.USD","LU2237443978.SGD","LU2456880835.USD","IE0009355771.USD","IE00B3T34201.USD","IE00BJJMRZ35.SGD","BK4534","LU0109394709.USD","LU0889565916.HKD","LU2237443549.SGD","BK4007","LU1829250122.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","AMGN","LU0708994859.HKD","LU0432979614.USD","PJP","LU1571399168.USD","LU0122379950.USD","LU2237443622.USD","IBBQ","IE00B4R5TH58.HKD","AZN","LU1057294990.SGD","LU2237443382.USD","SG9999001440.SGD","LU2237443465.HKD","IE00BJT1NW94.SGD","BIB","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670255552","title":"US Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2670255552","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670255552?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:31","pubTimestamp":1790605880,"startTime":"0","endTime":"0","summary":"FACTBOX-US drugmakers turn to China for licensing dealsSept 28 (Reuters)-MerckMRK.Non Monday agreed to payChinese biotechSciBrunch Therapeutics $400 million upfront for global rights to an experimenta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K0UD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2347655073.USD","IE00B4R5TH58.HKD","MEDX","LU2750360641.GBP","LU1188198961.HKD","IE000M9KFDE8.USD","LU2023250330.USD","LU0965509010.AUD","IE00BDGV0183.EUR","CANC","LU0466842654.USD","LU1988902786.USD","IE0000B7K699.USD","SG9999015978.USD","IE00BVYPNW00.USD","BK4007","BK4568","LU2125909247.SGD","LU1057294990.SGD","LU1923622614.USD","JDOC","LU1116320737.USD","LU1894683264.USD","LU2462591350.SGD","LU0823434740.USD","LU2063271972.USD","LU2750360997.AUD","IE00BN29S564.USD","LU1003077747.HKD","LU1699723380.USD","LU0097036916.USD","LU0289961442.SGD","GLAM","LU0098860793.USD","BBH","LU2361045086.USD","LU0949170772.SGD","IE00BLSP4239.USD","LU0124676726.USD","BK4139","LU1989772923.USD","ELIL","LU2362541513.USD","LU0237698245.USD","BK4599","LU0683600562.USD","LU1839511570.USD","LU2456880835.USD","LU1670711123.USD","LU0320765646.SGD","LU0868494617.USD","LU1236620834.HKD","LU2471134796.USD","LU1868836757.USD","LU2087625088.SGD","BK4559","LU1116320901.HKD","LU2097828557.USD","LU0455707207.USD","LU2265009873.SGD","LU2896262040.SGD","IE00BFSS8Q28.SGD","LU2756315664.SGD","IE0001KFT4U8.USD","LU1280957306.USD","LU2462157665.USD","LU0053666078.USD","IE0004445015.USD","LU0795875169.SGD","LU1917777945.USD","LU0096364046.USD","LU0471298694.HKD","LU0385154629.USD","MEDI","LU0070302665.USD","LU0786609619.USD","LU2213496289.HKD","LU1691799644.USD","LU1061106388.HKD","LU0354030438.USD","LU1670627923.USD","LU1883839398.USD","MHIP","IE00B42XCP33.USD","LU1093756325.SGD","LU0326950275.SGD","LU2488822045.USD","LU1974910355.USD","LU0211331839.USD","LU0289739343.SGD","LU0553294199.USD","SG9999014880.SGD","IE000BZT7R73.USD","LU0823434583.USD","SG9999015986.USD","HK0000165453.HKD","LU2360106947.USD","ILDR","IHE","LU0122379950.USD","LU2129689514.USD","IE00B1XK9C88.USD","LU2023250843.SGD","LU1069344957.HKD","LU2271345857.HKD","LU2746668974.SGD","IE00BFSS7M15.SGD","LU0208291251.USD","LU0029864427.USD","IE00BJJMRZ35.SGD","IE0002270589.USD","SG9999018857.SGD","IE00B1BXHZ80.USD","BK4588","SG9999014567.USD","LU0417517546.SGD","LU1983299246.USD","SG9999015945.SGD","VHT","LU0345770308.USD","LU2357627491.SGD","SG9999014898.SGD","SGXZ81514606.USD","LU0316494557.USD","LU0726765562.USD","BK4581","LLYZ","LU0471298777.SGD","IBB","LU0114720955.EUR","LU1732800096.USD","LU1934455863.HKD","LU2242644610.SGD","LU2264538146.SGD","LLYX","LU1831875114.USD","LU0320765489.SGD","LU2168564222.USD","LU2361044949.HKD","LU2237443382.USD","LU1941712264.USD","LU1064131342.USD","BK4550","LU0985481810.HKD","LU0061475181.USD","LU1894683348.USD","LU1267930490.SGD","LU0795875086.SGD","PFE","LU0985320562.USD","LU0069063385.USD","SG9999011175.SGD","LU1236620750.USD","LU0310800379.SGD","LU1066053197.SGD","LU0106261372.USD","LU0238689110.USD","LU0545039389.USD","IE00BGHQF631.EUR","LU0321505868.SGD","LU1720051017.SGD","LU0820562030.AUD","LU0128525929.USD","IE0004445239.USD","LU1430594728.SGD","LU2125154935.USD","FHLC","LU0912757837.SGD","BK4516","LU2111349929.HKD","LU2129689431.USD","LU2168564495.EUR","IE0009355771.USD","IE000MB6IJN5.SGD","LU2023251221.USD","LU0265550946.USD","LU0320765992.SGD","LU2360032135.SGD","SG9999014914.USD","CURE","LU1037948897.HKD","LU0661504455.SGD","SG9999001176.USD","LU0234572021.USD","LU0174119429.USD","LU0244354667.USD","SG9999015358.SGD","LU0823416689.USD","LU1941712348.USD","LU1969619763.USD","IE000F7OJYX1.SGD","IE00B7KXQ091.USD","LU1551013342.USD","LU0072461881.USD","LU0225771236.USD","LU1989772840.SGD","LU0820561818.USD","HRTS","LU0456855351.SGD","LU1814569148.SGD","LU1718418525.SGD","LU2237443549.SGD","XLV","LU0133085943.USD","BK1583","LU0130517989.USD","GB00BDT5M118.USD","LU2491049909.HKD","01801","BK1589","LU2108987350.USD","LU2237438978.USD","LU2089284900.SGD","LU0859254822.USD","GDOC","LU2461242641.AUD","LU0289739699.SGD","LU0203347892.USD","IE00B3PB1722.GBP","LU0672654240.SGD","LU1804176565.USD","LU0306807586.USD","IE00B775H168.HKD","LU1496350502.SGD","LU1571399168.USD","PJP","SG9999015341.SGD","LU2097828474.EUR","LU0158827781.USD","LU0648001328.SGD","BK4532","LU0109394709.USD","BK4566","LU2491050071.SGD","LU0198837287.USD","LU2168564065.EUR","LU2097828631.EUR","IE00BJJMRX11.SGD","LU2361044865.SGD","SGXZ57979304.SGD","LU1670710661.SGD","IE00BSNM7G36.USD","SG9999015952.SGD","LU2087621335.USD","LU2106854487.HKD","IE00B2B36J28.USD","LU0256863902.USD","LU2471134523.USD","LU0942090050.USD","LU1868836591.USD","LU1929549753.HKD","IE00BK4W5M84.HKD","SGXZ51526630.SGD","LU0861579265.USD","LU2237443465.HKD","THNR","LU0708994859.HKD","PPH","LU0353189680.USD","LU1066051225.USD","IE00BJJMRY28.SGD","LU0354030511.USD","LU0965509101.SGD","LU1023059063.AUD","LU2471134879.HKD","IE0002141913.USD","LU1267930573.SGD","SG9999002224.SGD","LU0738911758.USD","KURE","LU2552382058.USD","IE00B19Z3B42.SGD","SG9999014542.SGD","LU1127390331.HKD","LU0094547139.USD","LU2237443622.USD","LU2746668461.USD","ELIS","LU0323591593.USD","SG9999003800.SGD","LU1934455194.USD","SG9999001440.SGD","IBBQ","LU2756315318.SGD","LU2552382215.SGD","IE00B3T34201.USD","LU2129689605.HKD","LU1868836914.USD","LU0472753341.HKD","LU0203201768.USD","LU0256863811.USD","LU1629891620.HKD","LU0109391861.USD","SG9999013999.USD","LU0158827948.USD","LU2242646821.SGD","LU0058720904.USD","IE00BBT3K403.USD","LU0057025933.USD","LU2242652126.USD","IE00BFXG1179.USD","LU1066051498.USD","LU0130102774.USD","LU1585245621.USD","LU1366192091.USD","LU0203202063.USD","LU0511384066.AUD","LU0868494708.USD","MRK","IE00BJT1NW94.SGD","IE00BK4W5L77.USD","IE00BVYPNV92.GBP","LU1267930730.SGD","LU1244550221.USD","LU2468319806.SGD","LU1548497426.USD","LU0882574055.USD","IE00BJLML261.HKD","LU2112291526.USD","LU1496350171.SGD","IE00BKPKM429.USD","LU0211327993.USD","LU0079474960.USD","LU2347655156.SGD","LU0210536198.USD","LU2028103732.USD","LU1261432733.SGD","IE00B19Z3581.USD","AGNG","LU1244550577.SGD","LU0211328371.USD","LLY","LU0320765059.SGD","BK4534","LU0889565916.HKD","LU2362541273.HKD","LU0463099449.HKD","LU1623119135.USD","IE00BLSP4452.SGD","LLII","LU0820561909.HKD","BMY","LU2328871848.SGD","LU0708995401.HKD","LU1074936037.SGD","LU0203345920.USD","IYH","LU0943347566.SGD","LU1232071149.USD","LU2596442595.SGD","SG9999001176.SGD","TMED","IE00B4JS1V06.HKD","IE000WAW04H5.SGD","LU1989771016.USD","LU2552382132.HKD","ABBV","IE00BKDWB100.SGD","LU0882574139.USD","WDNA","LU2097828714.EUR","LU2471134952.CNY","LU1066051811.HKD","LU1868837136.USD","SG9999014906.USD","SG9999017495.SGD","LU2417539215.USD","BK4533","LU1670710588.SGD","LU1093756168.USD","LU1670628061.USD","BK1161","LU1201861249.SGD","LU1035773651.USD","OZEM","IE00BFTCPJ56.SGD","LU0310799852.SGD","LU0964807845.USD","LU0432979614.USD","IE00BWXC8680.SGD","SG9999002232.USD","LU1868837300.USD","SG9999014559.SGD","LU0225283273.USD","LU2491050154.USD","LU0162691827.USD","LU0225284248.USD","LU1291159041.SGD","LU1551013425.SGD","LU2357305700.SGD","LU1069347547.HKD","LU0149534421.HKD","LU0640476718.USD","LU0395794307.EUR","LU1162221912.USD","TRUH","LU0502904849.HKD","LU0607220059.USD","LU2089984988.USD","LU1244550494.USD","LU2168564149.EUR","IXJ","LU1035775433.USD","LU0689472784.USD","LU0965509283.SGD","LU2237443895.HKD","REGN","BMED","LU2236285917.USD","LU2237443978.SGD","SG9999018865.SGD","LU0306806265.USD","LU2133065610.SGD","LU2125154778.USD","LU1037948541.HKD","LU1712237335.SGD","BK4592","IE000SO60NU8.SGD","LU0353189763.USD","LU1732799900.SGD","LU2125909593.SGD","SG9999014575.USD","LU1979441026.SGD","LU2433249047.HKD","RXL","LU0234570918.USD","LU2168563687.JPY","LU1323610961.USD","LU0267386448.USD","LU1032466523.USD","BK4585","LU0980610538.SGD","LU0170899867.USD","LU0266013472.USD","LU0006306889.USD","LU2362540622.SGD","LU2324357040.USD","LU0965508806.USD","LU0787776722.HKD","IE00BN8TJ469.HKD","LU2602419157.SGD","LU0477156953.USD","SGXZ31699556.SGD","FTXH","LU0321505439.SGD","LU2023250504.SGD","LU2211815571.USD","LU1720051108.HKD","IE0005OL40V9.USD","LU0345770993.USD","LU1670711040.USD","LU2097828805.USD","LU1934455277.USD","PAWZ","LU0265550359.USD","SGXZ99366536.SGD","LU1145028129.USD","LU0689626769.HKD","LU2089283258.USD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}